Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-07

Clinical Trial Update: Oral Administration of Actitan-F in Paediatric Diarrhoea [NA]

View source ↗

Summary

An update on a clinical trial evaluating oral Actitan-F for chronic diarrhea in infants and young children; the study status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actitan-F

Snippet

Sponsor: Aboca Spa Societa' Agricola | Conditions: Chronic Diarrhoea of Infants and/or Young Children | NA | Status: UNKNOWN